Cite Filings / SCTX / 0000902664-26-003281

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Scribe Therapeutics, Inc. Filed 2026-07-30 Acc 0000902664-26-003281

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-07-30 SCHEDULE 13D Beneficial Ownership Report
2026-07-30 SCHEDULE 13D Beneficial Ownership Report
2026-07-29 4 10% owner acquired 12,511 shares (conversion)
2026-07-29 4 10% owner bought 333,333 shares at $15.00 ($4,999,995)
2026-07-29 4 Director bought 1,000,000 shares at $15.00 ($15,000,000)
2026-07-29 4 Director bought 1,000,000 shares at $15.00 ($15,000,000)
2026-07-29 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…